Characterization of brain morphology associated with metabolic dysfunction‐associated steatotic liver disease in the UK Biobank
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Wenxiao Fan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Department of Neurology, Shandong Provincial Hospital…. Hauptthemen laut MEDLINE: Brain, Fatty Liver. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation, Wellcome Trust.
Abstract (Originalsprache)
Background
Emerging evidence has linked metabolic dysfunction‐associated steatotic liver disease (MASLD) with accelerated cognitive decline and dementia. We aimed to investigate the associations of MASLD with volumes of total brain tissue and subcortical grey matter, and white matter microstructures in the UK Biobank.
Methods
This cross‐sectional study included 29,195 individuals (aged 45–82 years) from the UK Biobank who undertook a magnetic resonance imaging (MRI) sub‐study between 2014 and 2022. The brain MRI covers three modalities (T1, T2 FLAIR, and diffusion). Volumes of grey matter, subcortical grey matter structures, and regional cortex were derived from T1‐weighted images. Fractional anisotropy (FA) and mean diffusivity (MD) were derived from diffusion tensor imaging (DTI) to assess global and tract‐specific microstructure. MASLD was defined as the MRI‐derived proton density fat fraction (MRI‐PDFF) ≥5% and the presence of at least one cardiometabolic criterion. Data were analysed using multiple linear regression models.
Results
MASLD was significantly associated with smaller volumes of total grey matter and subcortical grey matter ( p < 0.05) and reduced Alzheimer's disease (AD)‐signature cortical thickness (multivariable‐adjusted β = −0.04; 95% confidence interval [CI]: −0.07, −0.01). Having MASLD was associated with higher total white matter hyperintensity (WMH) volume (multivariable‐adjusted β = 0.12; 95% CI: 0.10, 0.15). For white matter microstructure, MASLD was associated with increased global FA (multivariable‐adjusted β = 0.05; 95% CI: 0.03, 0.08) and reduced global MD (multivariable‐adjusted β = −0.04; 95% CI: −0.07, −0.01).
Conclusions
Brain morphology associated with MASLD is characterized by smaller subcortical grey matter volume and higher coherence but lower magnitudes of white matter microstructure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, People's Repu…
- Shandong Institute of Brain Science and Brain-inspired Research, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, People's Republic of Ch…
- Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, People's Republic of China.
- Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Stockholm University, Stockholm, Sweden.
ORCID-Profile: Yongxiang Wang
Förderung
- National Natural Science Foundation of China
- Shandong Provincial Natural Science Foundation
- Wellcome Trust
- Swedish Research Council
- Swedish Foundation for International Cooperation in Research and Higher Education
- Alzheimer's Association
- Natural Science Foundation of Shandong Province
- Vetenskapsrådet
Zitieren
APA
Fan, W., Yang, S., Wei, Y., Tian, M., Liu, Q., Li, X., Ding, J., Li, X., Mao, M., Han, X., Du, Y., Qiu, C., Dong, Y., & Wang, Y. (2025). Characterization of brain morphology associated with metabolic dysfunction‐associated steatotic liver disease in the UK Biobank. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16362
Vancouver
Fan W, Yang S, Wei Y, Tian M, Liu Q, Li X, et al. Characterization of brain morphology associated with metabolic dysfunction‐associated steatotic liver disease in the UK Biobank. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16362
BibTeX
@article{Fan2025,
author = {Fan, Wenxiao and Yang, Shuping and Wei, Yiran and Tian, Minle and Liu, Qianying and Li, Xiaomeng and Ding, Jiahao and Li, Xuewei and Mao, Ming and Han, Xiaolei and Du, Yifeng and Qiu, Chengxuan and Dong, Yi and Wang, Yongxiang},
title = {Characterization of brain morphology associated with metabolic dysfunction‐associated steatotic liver disease in the UK Biobank},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16362}
}
EUVIMED